These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Prando A; Kurhanewicz J; Borges AP; Oliveira EM; Figueiredo E Radiology; 2005 Sep; 236(3):903-10. PubMed ID: 16118169 [TBL] [Abstract][Full Text] [Related]
17. Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T. Kobus T; Vos PC; Hambrock T; De Rooij M; Hulsbergen-Van de Kaa CA; Barentsz JO; Heerschap A; Scheenen TW Radiology; 2012 Nov; 265(2):457-67. PubMed ID: 22843767 [TBL] [Abstract][Full Text] [Related]
18. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Zakian KL; Sircar K; Hricak H; Chen HN; Shukla-Dave A; Eberhardt S; Muruganandham M; Ebora L; Kattan MW; Reuter VE; Scardino PT; Koutcher JA Radiology; 2005 Mar; 234(3):804-14. PubMed ID: 15734935 [TBL] [Abstract][Full Text] [Related]
19. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Fütterer JJ; Heijmink SW; Scheenen TW; Veltman J; Huisman HJ; Vos P; Hulsbergen-Van de Kaa CA; Witjes JA; Krabbe PF; Heerschap A; Barentsz JO Radiology; 2006 Nov; 241(2):449-58. PubMed ID: 16966484 [TBL] [Abstract][Full Text] [Related]
20. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Akin O; Sala E; Moskowitz CS; Kuroiwa K; Ishill NM; Pucar D; Scardino PT; Hricak H Radiology; 2006 Jun; 239(3):784-92. PubMed ID: 16569788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]